Abion AB news and milestones

Abion / Insights & News / Pepper Pig Scores a Big Win Against the Big Bad Wolfoo Pepper Pig Scores a Big Win Against the Big Bad Wolfoo 15, September 2026 Legal Case Files Tradem…

Abion / Insights & News / When can freedom of expression justify the use of a well-known trade mark? When can freedom of expression justify the use of a well-known trade mark? 11…

Abion / Webinars & Podcasts / Abion Accento Ep. 2 Diane Lau Trademark Program Lead, Meta ex-GoPro, Yahoo & MoFo Abion Accento Ep. 2 Diane Lau Trademark Program Lead, Meta ex-GoPr…

Abion / Insights & News / Abion is admitted to SEPAF and takes its place in the Swedish IP network of the industry's leading firms Abion is admitted to SEPAF and takes its place…

Abion / Insights & News / Türkiye: New Regulatory Requirements for Game Platforms Taking Effect on 1 November 2026 Türkiye: New Regulatory Requirements for Game Platforms Taking…

Abion / Insights & News / Chris Stussy Becomes Chris Stassy: When Your Name is Also Your Brand Chris Stussy Becomes Chris Stassy: When Your Name is Also Your Brand 24, August 202…

A Turkish IP court has protected a commonplace word linked to a video game city, recognising acquired distinctiveness built through decades of use.

Abion / Insights & News / When Parody Meets Trade Marks: Lessons from Australia's 'Swim Shady' Decision When Parody Meets Trade Marks: Lessons from Australia's 'Swim Shady' Decis…

Abion / Insights & News / Jersey becomes a standalone designation under the Madrid System from 1 August 2026 Jersey becomes a standalone designation under the Madrid System from…

Abion / Insights & News / The Battle for "The Best": What FIFA, the Ballon d'Or and Football's Award Wars Reveal About Brand Power The Battle for "The Best": What FIFA, the Ballo…

ABION Presents Preclinical Data at AACR Showing IFN-β Antibody Fusion ABN202 Outperforms TROP2-Targeting ADCs

Abion says it has brought on board Matt Serlin as its first US hire to meet client demand for 'full circle' trademark and domain name services

ABION transfers 1.8 trillion won technology for cancer drug targeting CLDN3 ABIONs revolutionary antibody technology signed for 1.8 trillion won to co

ABION Hits Trading Ceiling After 1.8 Trillion Joint Drug Development Deal ABION achieved a ceiling price immediately after the market opened on the

ABION announced on the 9th that it has achieved a cumulative total of 15 contracted service projects from government departments related to national d

Abion announced on the 30th that it has signed a joint research agreement with the National Cancer Institute (NCI), a branch of the U.S. National Inst